本文關鍵詞：我國當前藥品短缺的經濟學分析　出處：《現代經濟探討》2017年10期 　論文類型：期刊論文

  更多相關文章： 藥品短缺 醫(yī)療改革 低價藥 罕見病藥

【摘要】：藥品短缺現象及其直接原因,可以從非均衡理論、壟斷理論與制度經濟學角度進行分析,價格管制、地方招標采購、新藥審批等制度中的設計缺陷是造成我國藥品短缺的主要原因。解決當前藥品短缺問題的重點在于恢復藥品市場定價機制,構建更具競爭性的招標采購機制,建立招標市場以外的藥品自由流通市場,降低市場壁壘,防止市場準入管制與招標機制成為分割藥品市場和保護本地企業(yè)的手段,同時加強政府履行維護市場有效競爭的職責,并為特殊性、公益性藥品提供最后的供應保障。
[Abstract]:The phenomenon of drug shortage and its direct causes can be analyzed from the angle of non-equilibrium theory, monopoly theory and institutional economics, price control, local bidding and procurement. The design defects in the new drug examination and approval system are the main causes of drug shortage in China. The key to solve the current drug shortage problem lies in the restoration of drug market pricing mechanism and the construction of a more competitive bidding procurement mechanism. Establish the free circulation market of drugs outside the bidding market, reduce the market barriers and prevent the market access control and bidding mechanism from becoming the means to separate the drug market and protect the local enterprises. At the same time, strengthen the government's duty to maintain effective competition in the market, and provide the final supply guarantee for particularity and public welfare drugs.
【作者單位】： 中國社會科學院研究生院工業(yè)經濟系;中國社會科學院工業(yè)經濟研究所;
【分類號】：F426.72
【正文快照】： 品出現短缺。由此可見,藥品短缺問題并沒有得到一、問題的提出根本解決,“一藥難求”的現象甚至使十幾元、幾十元2009年新一輪醫(yī)改以來,我國堅持立足國情、公的藥品炒到上千元,增加了患者醫(yī)療負擔,提高了醫(yī)平與效率統(tǒng)一、市場與政府結合和統(tǒng)籌兼顧的原則,療機構的費用成本,也，

本文編號：1377237